This bill requires federal agencies to modernize how they review existing regulations after implementation. It mandates that agencies make regulations available in digital formats within 180 days and provides guidance on using technology like AI to identify outdated, redundant, or error-prone rules. Agencies must submit detailed implementation plans within two years, including how they’ll use technology for reviews, and begin executing these plans within 180 days of plan approval. The bill directly affects all federal agencies responsible for creating regulations (e.g., EPA, FDA), streamlining their retrospective review process through technology and standardized digital access.
This bill establishes federal governance requirements for artificial intelligence systems used by government agencies. It requires agencies to create detailed AI governance charters for high-risk systems, including information about development, training data, and how the system is used. Agencies must provide plain language notifications to individuals affected by AI-driven decisions and maintain public inventories of AI systems through a Federal AI System Inventory. The bill creates a new oversight role within the Office of Management and Budget and mandates regular evaluations of agency AI governance practices. These requirements apply to all federal agencies and their contractors using AI systems that make decisions affecting individuals.
HR 3269, the Law Enforcement Innovate to De-Escalate Act, exempts specific less-than-lethal projectile devices from federal firearm taxes and National Firearms Act restrictions. The bill defines these devices as those firing projectiles at under 500 feet per second and designed not to cause death or serious injury. This directly affects law enforcement agencies using such devices and manufacturers producing them, by removing tax burdens and registration requirements. The key change is creating a clear legal exemption for these devices under federal law, streamlining their use for de-escalation purposes.
The FOCA Act of 2023 requires federal agencies to stop mandating or banning contractor agreements with labor organizations (like union contracts) in construction project bids and contracts. It directly affects federal contractors, subcontractors, and agencies managing construction projects funded by the government. The bill prohibits favoring or penalizing contractors based on their labor affiliation status, aiming to promote fair competition and reduce costs. It also mandates updates to federal contracting rules within 60 days of enactment to implement these changes.
This resolution (SRES 931) is a formal expression of Senate appreciation for Ambassador Michael Herzog's service as Israel's Ambassador to the United States from 2021 to 2024. It recognizes his diplomatic work, including fostering bipartisan U.S.-Israel relations and advancing the Abraham Accords, but does not create any new laws, policies, or obligations. As a ceremonial resolution, it directly affects no individuals or entities and has no legal or practical impact beyond the symbolic gesture. The Senate unanimously commends his efforts to strengthen U.S.-Israel ties during a challenging period.
Tyler’s Law requires hospitals and medical examiners or coroners to report incidents involving a child’s death or serious injury linked to children’s products (like toys) or durable infant/toddler products (like cribs) to the Consumer Product Safety Commission. Hospitals must submit detailed reports within 7 days, including the child’s age and injury details, product information, and incident circumstances. Medical examiners and coroners must report child deaths associated with such products within 7 days, and failure to comply could make their offices ineligible for certain federal grants. The law applies to incidents occurring 180 days after enactment and uses existing definitions for "children’s product" from consumer safety laws.
This bill prohibits federal criminal prosecution for performing "gender-related medical treatment" on minors under specific circumstances, defined as medical procedures or medications intended to change a minor's gender presentation (e.g., puberty blockers, surgeries like hysterectomy or phalloplasty). Exceptions apply for medically necessary treatments for disorders of sex development, ambiguous biological characteristics, or injuries from prior treatments. It also bans Medicare coverage for such treatments (except for the medical exceptions) and prohibits federal funding for any gender-related medical care for minors. The bill directly affects minors seeking gender-affirming care, healthcare providers offering these treatments, and federal health programs like Medicare.
The VALOR Act of 2024 establishes specific criteria for determining when a democratically elected government is in power in Venezuela, requiring free and fair elections with international observers, respect for human rights, release of political prisoners, and restoration of democratic institutions. The bill authorizes sanctions against the Maduro regime, including financial restrictions on debt instruments, cryptocurrency transactions, and blocking property of the Venezuelan government. It creates mechanisms for the U.S. to provide humanitarian and democracy-building assistance through independent NGOs once a democratically elected government is recognized, with safeguards to ensure aid reaches the people of Venezuela. The bill requires regular reporting to Congress on sanctions implementation, assistance programs, and foreign entities doing business with the Maduro regime.
The Pharmacists Fight Back Act (HR 9096) sets new rules for Pharmacy Benefits Managers (PBMs) working with federal health care programs like Medicare Part D and Medicaid. It requires PBMs to reimburse in-network pharmacies at a rate covering the drug's actual cost plus a small fee (capped at $25), and to reduce patient cost-sharing by at least 80% of rebates received from drug manufacturers. The bill bans PBMs from steering patients to specific pharmacies, charging patients more than pharmacies are paid, or using rebates to lower pharmacy payments after claims are processed. It also mandates public reporting of drug pricing data to improve transparency, ensuring patients and pharmacies receive fairer treatment under federal health programs.
This bill would make it a federal crime for licensed physicians to perform or attempt to perform an abortion at any point after fertilization, with limited exceptions to save a pregnant woman's life when facing a physical condition, or to remove a dead unborn child from miscarriage or stillbirth, or for ectopic pregnancy. It would prohibit federal funding for abortions through programs like Medicaid, the Children's Health Insurance Program, Indian Health Service, Veterans Health Administration, TRICARE, and Title X family planning services, except in those limited circumstances. The bill also prohibits group health plans and insurance from covering abortions, with the same exceptions. It defines "unborn child" as a human being from fertilization until live birth and "abortion" as any action intended to terminate a pregnancy.
This bill requires Medicare Advantage plans to implement electronic prior authorization systems by 2027 and publish detailed data on their approval and denial rates for medical services by 2026. It directly affects Medicare Advantage plans (private insurers offering Medicare coverage) and their enrollees (seniors 65+), mandating transparency about prior authorization decisions, processing times, and appeal outcomes. Key provisions include requiring plans to report annual statistics on request approvals/denials, average processing times, and use of technology, with this data published publicly by the Centers for Medicare & Medicaid Services. The bill also sets timelines for plan responses to prior authorization requests and mandates reports to Congress on implementation and impacts.
The MEGOBARI Act directs the U.S. government to investigate and address democratic backsliding in Georgia. It requires reports within 90 days on Georgian corruption tied to Russian interests, sanctions evasion, and Russian intelligence assets, followed by potential sanctions against Georgian officials deemed responsible for undermining democracy or advancing Russian-style laws. The bill also establishes a U.S. democracy monitoring task force in Georgia and links additional U.S. aid - including trade negotiations, visa liberalization, economic packages, and defense support - to Georgia's progress toward fair elections and a free political environment. These provisions directly affect Georgia's government officials (who could face sanctions) and Georgia's eligibility for U.S. assistance. The bill does not impose new sanctions but mandates U.S. agencies to identify and sanction specific Georgian individuals under existing legal authorities.
